EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view

Fatemeh Ebadi Meinag, Mina Fatahi, Vahid Vahedian, Nazila Fathi Maroufi, Bashir Mosayyebi, Elham Ahmadi, Mohammad Rahmati

Functional & Integrative Genomics · 2024

DOI: 10.1007/s10142-024-01431-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Functional & Integrative Genomics, 2024. Verfasst von Fatemeh Ebadi Meinag und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Doxorubicin, Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 174 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) are a group of small non-coding RNAs and play an important role in controlling vital biological processes, including cell cycle control, apoptosis, metabolism, and development and differentiation, which lead to various diseases such as neurological, metabolic disorders, and cancer. Chemotherapy consider as gold treatment approaches for cancer patients. However, chemotherapeutic is one of the main challenges in cancer management. Doxorubicin (DOX) is an anti-cancer drug that interferes with the growth and spread of cancer cells. DOX is used to treat various types of cancer, including breast, nervous tissue, bladder, stomach, ovary, thyroid, lung, bone, muscle, joint and soft tissue cancers. Also recently, miRNAs have been identified as master regulators of specific genes responsible for the mechanisms that initiate chemical resistance. miRNAs have a regulatory effect on chemotherapy resistance through the regulation of apoptosis process. Also, the effect of miRNAs p53 gene as a key tumor suppressor was confirmed via studies. miRNAs can affect main biological pathways include PI3K pathway. This review aimed to present the current understanding of the mechanisms and effects of miRNAs on apoptosis, p53 and PTEN/PI3K/Akt signaling pathway related to DOX resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDoxorubicinDrug Resistance, NeoplasmNeoplasmsHumansPTEN PhosphohydrolaseApoptosisSignal TransductionPhosphatidylinositol 3-KinasesTumor Suppressor Protein p53AnimalsGene Expression Regulation, NeoplasticProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

DoxorubicinDrug resistanceMiRNAsNon-coding RNAs

Substanzen

MicroRNAsDoxorubicinPTEN PhosphohydrolasePhosphatidylinositol 3-KinasesTumor Suppressor Protein p53PTEN protein, humanProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Hematology, Transfusion Medicine and Cellular Therapy/Cell Therapy Center (CTC-USP), Clinical Hospital and Cancer Institute (ICESP), Faculty of Medicine, University of Sao Paulo (FMUSP-HC), Sao Paulo, Braz…
  • Department of Clinical Medicine, Division of Medical Investigation Laboratory (LIM/31), Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology and Immuno-Oncology, Clinical Hospital, Faculty of Medicine, University…
  • Comprehensive Center for Translational and Precision Oncology (CTO), SP State Cancer Institute (ICESP), Sao Paulo, Brazil.
  • Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. n.fathi6788@gmail.com.

Zitieren

APA

Meinag, F. E., Fatahi, M., Vahedian, V., Maroufi, N. F., Mosayyebi, B., Ahmadi, E., & Rahmati, M. (2024). Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view. Functional & Integrative Genomics. https://doi.org/10.1007/s10142-024-01431-x

Vancouver

Meinag FE, Fatahi M, Vahedian V, Maroufi NF, Mosayyebi B, Ahmadi E, et al. Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view. Functional & Integrative Genomics. 2024. doi:10.1007/s10142-024-01431-x

BibTeX
@article{Meinag2024,
  author = {Meinag, Fatemeh Ebadi and Fatahi, Mina and Vahedian, Vahid and Maroufi, Nazila Fathi and Mosayyebi, Bashir and Ahmadi, Elham and Rahmati, Mohammad},
  title = {Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view},
  journal = {Functional & Integrative Genomics},
  year = {2024},
  doi = {10.1007/s10142-024-01431-x}
}
Kostenlos starten →